Share on StockTwits
 

Investment analysts at Ladenburg Thalmann lifted their price target on shares of Questcor Pharmaceuticals (NASDAQ:QCOR) from $84.00 to $85.00 in a note issued to investors on Wednesday, StockRatingsNetwork reports. The firm currently has a “buy” rating on the stock. Ladenburg Thalmann’s target price would indicate a potential upside of 8.07% from the company’s current price.

In other Questcor Pharmaceuticals news, Director Broadwood Partners Lp unloaded 306,400 shares of Questcor Pharmaceuticals stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $74.94, for a total value of $22,961,616.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of Questcor Pharmaceuticals (NASDAQ:QCOR) traded down 2.62% during mid-day trading on Wednesday, hitting $76.59. 3,397,866 shares of the company’s stock traded hands. Questcor Pharmaceuticals has a 52 week low of $26.80 and a 52 week high of $80.25. The stock’s 50-day moving average is $64.63 and its 200-day moving average is $61.81. The company has a market cap of $4.510 billion and a price-to-earnings ratio of 18.06. Questcor Pharmaceuticals also was the recipient of unusually large options trading activity on Tuesday. Investors purchased 11,353 put options on the company. This represents an increase of approximately 377% compared to the average volume of 2,380 put options.

Questcor Pharmaceuticals (NASDAQ:QCOR) last released its earnings data on Tuesday, February 25th. The company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. The company had revenue of $243.00 million for the quarter, compared to the consensus estimate of $244.15 million. Analysts expect that Questcor Pharmaceuticals will post $6.73 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, April 25th. Shareholders of record on Friday, April 18th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Tuesday, April 15th.

Several other analysts have also recently commented on the stock. Analysts at Oppenheimer raised their price target on shares of Questcor Pharmaceuticals from $90.00 to $99.00 in a research note on Wednesday. They now have an “outperform” rating on the stock. Separately, analysts at CRT Capital raised their price target on shares of Questcor Pharmaceuticals from $61.00 to $72.00 in a research note on Wednesday. They now have a “fair value” rating on the stock. Finally, analysts at Piper Jaffray raised their price target on shares of Questcor Pharmaceuticals from $85.00 to $98.00 in a research note on Wednesday. They now have an “overweight” rating on the stock. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $84.11.

Questcor Pharmaceuticals, Inc (NASDAQ:QCOR) is a biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.